John Smulian1, Susan Shen-Schwarz, William Scorza, Wendy Kinzler, Anthony Vintzileos. 1. Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Maternal-Fetal Medicine, UMDNJ-RWJ Medical School/RWJ University Hospital, Clinical Academic Building, 125 Paterson Street, Room-2140, New Brunswick, NJ 08901, USA.
Abstract
OBJECTIVE: To determine whether differences in the clinical entities of HELLP syndrome and severe preeclampsia are associated with different placental lesions. STUDY DESIGN: This was a case control study of singleton pregnancies with HELLP syndrome or severe preeclampsia. Archived pathology slides were retrieved and reviewed. Clinical and histopathological features were compared between the two groups. RESULTS: There were 31 women with HELLP syndrome and 56 with severe preeclampsia. HELLP syndrome was associated with epigastric pain and higher levels of LDH, bilirubin, liver enzymes and fibrin degradation products. Hemoglobin, hematocrit and platelet counts were lower. Abruption lesions of the placenta were less common with HELLP syndrome (Odds Ratio 0.1 95% Confidence Interval 0.01,0.8). None of the other 22 placental features examined were different between the two conditions. CONCLUSION: The significant overlap between HELLP syndrome and severe preeclampsia for both clinical and placental features suggests that the two conditions represent a spectrum of essentially the same pathophysiologic process.
OBJECTIVE: To determine whether differences in the clinical entities of HELLP syndrome and severe preeclampsia are associated with different placental lesions. STUDY DESIGN: This was a case control study of singleton pregnancies with HELLP syndrome or severe preeclampsia. Archived pathology slides were retrieved and reviewed. Clinical and histopathological features were compared between the two groups. RESULTS: There were 31 women with HELLP syndrome and 56 with severe preeclampsia. HELLP syndrome was associated with epigastric pain and higher levels of LDH, bilirubin, liver enzymes and fibrin degradation products. Hemoglobin, hematocrit and platelet counts were lower. Abruption lesions of the placenta were less common with HELLP syndrome (Odds Ratio 0.1 95% Confidence Interval 0.01,0.8). None of the other 22 placental features examined were different between the two conditions. CONCLUSION: The significant overlap between HELLP syndrome and severe preeclampsia for both clinical and placental features suggests that the two conditions represent a spectrum of essentially the same pathophysiologic process.
Authors: T Várkonyi; B Nagy; T Füle; A L Tarca; K Karászi; J Schönléber; P Hupuczi; N Mihalik; I Kovalszky; J Rigó; H Meiri; Z Papp; R Romero; N G Than Journal: Placenta Date: 2010-06-11 Impact factor: 3.481
Authors: Andrea Balogh; Judit Pozsgay; János Matkó; Zhong Dong; Chong Jai Kim; Tibor Várkonyi; Marei Sammar; János Rigó; Hamutal Meiri; Roberto Romero; Zoltán Papp; Nándor Gábor Than Journal: Am J Obstet Gynecol Date: 2011-03-22 Impact factor: 8.661
Authors: Muhammad Asim Rana; Ahmed F Mady; Abdullah Ali Lashari; Rehab Eltreafi; Nicola Fischer-Orr; Kamal Naser Journal: Case Rep Crit Care Date: 2018-05-27